CTC-25953-74096
4 vaccinations
5 coded responses
36 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 471 / IN
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Pfizer-BioNTech
-
2021-01-30
Registered in v-safe
-
2021-01-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-14
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-19
-
2021-02-20
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia — Feeling: Fair · Site: Pain · Fever · HeadacheFree text: Skin tinglingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Survey response — days 1–6 daily, dose 2MedDRA: Vision blurred, Visual impairment — Feeling: Good · Site: Pain · HeadacheFree text: Mild blurred vision wavy linesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-14
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-23
- 2021-08-20
-
2021-09-01
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Survey response — day 28, dose 3MedDRA: Chills, Fatigue, Headache, Injection site pain, Myalgia, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: During the 24 hours after the third vaccine I had a fever of 102 degrees, headache, chills, sore injection site fatigue and myalgias. The fever and chills resolved at around 30 hours, but the headache, fatigue, sore site and myalgias persisted for aMedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-13
- 2021-12-01
- 2022-03-02
-
2022-04-08
Dose 4 — Pfizer-BioNTech
-
2022-04-15
Survey response — day 7, dose 4MedDRA: Chills, Headache, Pyrexia, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: 12 hours after the 4th injection I had headache, fever and chills. Chills for 2 hours; fever for 7 hours ; and headache for 2 days. This was roughly the same as for the 3 preceding injections.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
-
2022-05-20
Survey response — day 42, dose 4MedDRA: Asthenia, Fatigue, Hospitalisation, Pneumonia, Pyrexia — Feeling: Poor · Get care from a doctor or other healthcare professional · HospitalizationFree text: Community acquired pneumonia. Fever. Weakness. Exhaustion. Hospitalized, given antibiotics and oxygen.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Report sent to call center — day 42, dose 4Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-05-24
- 2022-07-08
- 2022-10-07
- 2023-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-09-01 | Pfizer-BioNTech | No |
| 4 | 2022-04-08 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Skin tingling
Systemic reaction (other): Mild blurred vision wavy lines
Release 9 — day 28, dose 3
Symptoms: During the 24 hours after the third vaccine I had a fever of 102 degrees, headache, chills, sore injection site fatigue and myalgias. The fever and chills resolved at around 30 hours, but the headache, fatigue, sore site and myalgias persisted for a cut off by CDC
Release 11 — day 7, dose 4
Systemic reaction (other): 12 hours after the 4th injection I had headache, fever and chills. Chills for 2 hours; fever for 7 hours ; and headache for 2 days. This was roughly the same as for the 3 preceding injections.
Release 11 — day 42, dose 4
Symptoms: Community acquired pneumonia. Fever. Weakness. Exhaustion. Hospitalized, given antibiotics and oxygen.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Chills | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Pyrexia | · | · | ✓ |
| SRO | Reaction to previous exposure to any vaccine | · | · | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release